ABVC BIOPHARMA, INC. Interest Expense Nonoperating
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseNonoperating · last filed 2026-08-12
- ABVC BIOPHARMA, INC. interest expense nonoperating for the quarter ending 2026-06-30 was $42.32K, a 67.30% decline year-over-year.
- ABVC BIOPHARMA, INC. interest expense nonoperating for the quarter ending 2026-03-31 was $49.38K, a 77.85% decline year-over-year.
- ABVC BIOPHARMA, INC. interest expense nonoperating for the quarter ending 2025-12-31 was $32.55K, a 84.98% decline year-over-year.
- ABVC BIOPHARMA, INC. interest expense nonoperating for the quarter ending 2025-09-30 was $30.96K, a 85.96% decline year-over-year.
- ABVC BIOPHARMA, INC. interest expense nonoperating for fiscal 2025 was $415.89K, a 49.64% decline from fiscal 2024.
- ABVC BIOPHARMA, INC. interest expense nonoperating for fiscal 2024 was $825.90K, a 37.13% decline from fiscal 2023.
- ABVC BIOPHARMA, INC. interest expense nonoperating for fiscal 2023 was $1.31M.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 3 month as first filed | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 6 month as first filed | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 9 month as first filed | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $42.32K 10-Q · filed 2026-08-12 | $91.70K 10-Q · filed 2026-08-12 | $124.25K derived: sum of 3 quarters · filed 2026-08-12 | $155.21K derived: sum of 4 quarters · filed 2026-08-12 | |||
| 2026-03-31 | $49.38K 10-Q · filed 2026-05-18 | $81.93K derived: sum of 2 quarters · filed 2026-05-18 | $112.89K derived: sum of 3 quarters · filed 2026-05-18 | $242.30K derived: sum of 4 quarters · filed 2026-08-12 | |||
| 2025-12-31 | $32.55K derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-03-03 | $63.51K derived: sum of 2 quarters · filed 2026-03-03 | $192.92K derived: sum of 3 quarters · filed 2026-08-12 | $415.89K 10-K · filed 2026-03-03 | |||
| 2025-09-30 | $30.96K 10-Q/A · filed 2026-03-03 | $160.37K derived: sum of 2 quarters · filed 2026-08-12 | $383.34K 10-Q/A · filed 2026-03-03 | $600.05K derived: sum of 4 quarters · filed 2026-08-12 | |||
| 2025-06-30 | $129.41K 10-Q · filed 2026-08-12 | $352.38K 10-Q · filed 2026-08-12 | $569.10K derived: sum of 3 quarters · filed 2026-08-12 | $789.52K derived: sum of 4 quarters · filed 2026-08-12 | |||
| 2025-03-31 | $222.97K 10-Q · filed 2026-05-18 | $439.68K derived: sum of 2 quarters · filed 2026-05-18 | $660.11K derived: sum of 3 quarters · filed 2026-05-18 | $867.19K derived: sum of 4 quarters · filed 2026-05-18 | |||
| 2024-12-31 | $216.72K derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-03-03 | $437.14K derived: sum of 2 quarters · filed 2026-03-03 | $644.22K derived: sum of 3 quarters · filed 2026-03-03 | $825.90K 10-K · filed 2026-03-03 | |||
| 2024-09-30 | $220.43K 10-Q/A · filed 2026-03-03 | $219.53K 10-Q · filed 2024-11-14 | $427.51K derived: sum of 2 quarters · filed 2026-03-03 | $609.18K 10-Q/A · filed 2026-03-03 | $1.16M 10-Q · filed 2024-11-14 | $532.82K derived: sum of 4 quarters · filed 2026-03-03 | |
| 2024-06-30 | $207.08K 10-Q · filed 2025-08-13 | $260.03K 10-Q · filed 2024-08-14 | $388.75K 10-Q · filed 2025-08-13 | $944.72K 10-Q · filed 2024-08-14 | $312.39K derived: sum of 3 quarters · filed 2025-08-13 | $1.53M derived: sum of 4 quarters · filed 2025-08-13 | |
| 2024-03-31 | $181.68K 10-Q · filed 2025-04-30 | $105.31K derived: sum of 2 quarters · filed 2025-04-30 | $1.32M derived: sum of 3 quarters · filed 2025-04-30 | $1.44M derived: sum of 4 quarters · filed 2025-04-30 | |||
| 2023-12-31 | -$76.37K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $1.14M derived: sum of 2 quarters · filed 2025-04-15 | $1.26M derived: sum of 3 quarters · filed 2025-04-15 | $1.31M 10-K · filed 2025-04-15 | |||
| 2023-09-30 | $1.22M 10-Q · filed 2024-11-14 | $1.33M derived: sum of 2 quarters · filed 2024-11-14 | $1.39M 10-Q · filed 2024-11-14 | ||||
| 2023-06-30 | $114.75K 10-Q · filed 2024-08-14 | $171.41K 10-Q · filed 2024-08-14 |